The department of medicine is saddened to share that former colleague Howard Ozer, MD, PhD, passed away on April 6, 2018.

image2
Photo credit: UIC Today

 Dr. Ozer served as Division Chief of Hematology and Oncology at UNC School of Medicine 1982 to 1993 and was associate director for clinical affairs at UNC Lineberger. He was the Eileen Lindsay Heidrick Professor of Oncology at the University of Illinois College of Medicine at Chicago at the time of his death.

Dr. Ozer made many notable contributions to the oncology field, including a seminal study that demonstrated that recombinant methionyl granulocyte colony-stimulating factor can reduce the onset of fever and infection for patients receiving chemotherapy for small cell lung cancer. He also is internationally known for his research work in the development of hematopoietic growth factors and cytokines and for his clinical trials in leukemia and lymphoma.

Dr. Ozer held a number of senior leadership positions during his career, including Director of the University of Illinois Cancer Center, Director of the Winship Cancer Center, Director of the Cancer Center of MCP Hahnemann University, and Director of the University of Oklahoma Cancer Center.

He was a wonderful colleague whose work advanced our knowledge and treatment of cancer. He will be missed.

More about his contributions to the oncology field can be found here.

Ron Falk, MD
Nan and Hugh Cullman Eminent Professor
Chair, Department of Medicine
Director, UNC Kidney Center
UNC School of Medicine

Shelton Earp, MD
Director, UNC Lineberger Comprehensive Cancer Center
Director, UNC Cancer Care
Lineberger Professor of Cancer Research
Professor of Medicine & Pharmacology
UNC School of Medicine

Lisa A. Carey, MD
Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research
Division Chief of Hematology and Oncology
UNC School of Medicine
Physician-in-Chief, N.C. Cancer Hospital
Associate Director, Clinical Research, UNC Lineberger Comprehensive Cancer Center